ZX-7101A clinical trials
How each study uses ZX-7101A is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- ZX-7101A 80mg
- 2
Studies by the year they started
5 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2023 | 3 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Nanjing Zenshine Pharmaceuticals (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ZX-7101A is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With InfluenzaCompletedPhase 3Nanjing Zenshine PharmaceuticalsNCT07095257Written as ZX-7101A for oral suspension
- Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult MalesCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT06841926Written as ZX-7101A dry suspension
- Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in ChinaCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT05720091Written as ZX-7101A 80mg
- Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy SubjectsCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT05711797Written as ZX-7101A 80mg
- A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult SubjectsCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT06057103Written as ZX-7101A and Oseltamivir